e-therapeutics (LON:ETX) Share Price Passes Above 200-Day Moving Average – Should You Sell?

e-therapeutics plc (LON:ETX)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 9.76 ($0.13) and traded as high as GBX 10.75 ($0.14). e-therapeutics shares last traded at GBX 9 ($0.12), with a volume of 2,518,125 shares changing hands.

e-therapeutics Trading Down 6.7 %

The company has a debt-to-equity ratio of 0.33, a current ratio of 22.20 and a quick ratio of 20.13. The firm has a fifty day simple moving average of GBX 9 and a two-hundred day simple moving average of GBX 9.73. The firm has a market capitalization of £52.59 million, a P/E ratio of -450.00 and a beta of 0.46.

About e-therapeutics

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.